The Role of Surgery in Cancer

Size: px
Start display at page:

Download "The Role of Surgery in Cancer"

Transcription

1 The Role of Surgery in Cancer Farhat VN Din Senior Lecturer Chief Scientist Office Senior Clinical Fellow & Consultant Colorectal Surgeon

2 Disclosure Surgeon Scientist Optimist My own views

3 The next few minutes Incidence & mortality trends Contribution of surgery to cancer management Translational research in cancer surgery Aligning priorities to accelerate translation

4 Incidence and Mortality

5 Cancer in the UK CRUK

6 Cancer Scotland All cancers Number Rate (ASR) UK average Incidence Mortality NCIN e-cancer atlas

7 Cancer Scotland All cancers Number Rate (ASR) UK average Incidence Mortality NCIN e-cancer atlas

8 Trends in Cancer Incidence Scotland , age-adjusted

9 Most Common Cancers in Scotland 2015

10 Observed and Projected Incidence and Mortality Rates Age-standardised Incidence Age-standardised Mortlaity CRUK: cruk.org/cancerstats

11 Incidence Projections for Scotland Scottish Cancer Registry

12 Multimodality Cancer Treatment Radiotherapy Surgery Chemotherapy

13 Extent to which surgery airbrushed from media striking A widely cited analysis of cancer research stories published between 1998 and 2006 on the BBC website chosen by the researchers as an ideal surrogate for overall media impact found that stories about cancer drugs dominated, accounting for around 20% of all coverage. Br J Can 2008, 99:569 76

14 Media Influences Public Attitudes and Policy

15 Contribution of Surgery to Cancer Management

16 Cancer patient registrations Patients undergoing Surgery for Cancer Scotland Surgery status Yes Surgery status No Surgery status Not Known ISD, Scotland

17 Cancer patient registrations Surgery as First Treatment for Cancer Patients Year total surgery radiotherapy chemotherapy hormone other ISD, Scotland

18 Evolution of cancer surgery Hippocrates ( BC) early cancer descriptions- thought to be incurable Roman physician Celsus (28-50 BC) After excision, even when a scar has formed, none the less the disease has returned. Noted no cure once spread Galen ( AD) oncos Surgery cures breast cancer if completely removed at an early stage William Handley 1900 permeation theory Cancer surgery pioneers: remove the entire tumour & lymph nodes Theodor Billroth 1872 oesop. resection William Halstead 1880s radcical mastectomy Steven Paget 1889 seed and soil George Beatson 1896 oophorectomy in breast ca

19 Advances in Cancer Surgery * anaesthesia Bernard Fisher, Cancer Research 2008

20 Advances in Cancer Surgery Bernard Fisher, Cancer Research 2008

21 Its about the result.. Not the tools

22 Radical surgery William Halsted Johns Hopkins radical mastectomy Mastectomy through the ages, Neddy Merrill

23 Maximal to minimally invasive surgery Open surgery Laparoscopic surgery Robotic surgery technological advance vs oncological advance preserve oncological principles

24 Surgical remains central to cancer management Screening Diagnosis ( resection / biopsy) Staging Prophylactic surgery Reconstruction Primary treatment Palliation

25 Prophylactic Surgery-Cancer prevention

26 Relevance to surgeon Identification of inherited syndromes Stratify risk Screening Tailor surgery Post-operative surveillance Clinically relevant somatic mutations

27 Prophylactic surgery benefits of resection of normal organ from an asymptomatic individual > risk of surgery

28 Prophylactic cancer-risk reducing surgery

29 Criteria for prophylactic surgery High penetrance of the mutation or high lifetime risk Reliable test : genetic testing sensitive method for determining if disease-free operative morbidity low function of the removed organ restored You et al. World J Surgery, 2007

30 Prophylactic Mastectomy in Preventing Breast Cancer Time to Breast Cancer Diagnosis in Female BRCA1 Mutation Carriers Rebbeck et al; JCO 2004, 22,

31 Effect of Prophylactic Oophorectomy Ovarian and Breast Cancer Risk in BRCA1/2 Carriers Rebbeck TR et al. N Engl J Med 2002;346:

32 Cumulative Survival of Screened vs Symptomatic FAP patients E K L Mallinson et al. Gut 2010;59:

33 Extended Colectomy reduces risk by 4-fold in Lynch Syndrome Anele et al. Colorectal Disease, (6) pages

34 Surgery as Primary Treatment

35 What is the Evidence-Base Supporting the Assertion that Surgery Can Cure Established Cancer? No randomised trials ever conducted of surgery versus no treatment Evidence base that surgery is beneficial is only indirect - Observational studies - Descriptive studies of case series - Comparative studies of different techniques/approaches - Evidence from within randomised trials of chemotherapy/radiotherapy - Randomised trials of surgery alone against radiotherapy/chemotherapy

36 Estimated Contribution to Cancer Cure Cytotoxic Chemotherapy Morgan G et al. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin Oncol 2004; 16:

37 Estimated Contribution to Cancer Cure Radiotherapy +/- ChemoRx for Rectal Cancer Preoperative chemoradiation versus radiation alone survival outcome Preoperative radiotherapy vs surgery alone absolute survival Gray R et al. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001;358(9290): De Caluwé L et al. Cochrane Database of Systematic Review. 28 FEB 2013 DOI: / CD pub3

38 Contribution of Surgery to Cancer Survival Radiotherapy/Neoadjuvant ChemoRadiotherapy Breast Cancer Rectal Cancer Breast-Conserving Surgery With or Without Radiotherapy J Natl Cancer Inst. 2004;96(2): Rahbari et al. Neoadjuvant Radiotherapy for Rectal Cancer: Meta-analysis of Randomized Controlled Trials. Ann Surg Oncol (2013) 20:

39 Surgical Debulking in Ovarian Cancer Overall Survival Progression-free Survival Dubois et al. Cancer 2009; 115,

40 Hepatic Resection for Colorectal Cancer Liver Metastases Radiofrequency ablation (RFA) vs Resection Van Amerongen et al. HPB 2017

41 Negative Surgical Resection Margin Key determinant of overall survival RO Resection: complete resection with no microscopic residual tumour R1 Resection: complete resection with no grossly visible tumour, microscopic cancer may be left behind (margins positive) R2 Resection: partial resection, with grossly visible tumour left behind

42 Hepatic Resection for Colorectal Cancer Liver Metastases Importance of clear resection margin N=557 CRC patients with liver mets Poultsides GA et al. HPB ; 43-9

43 Evidence Base that Surgery can Cure Cancer I IIA IIB III IV Evidence obtained from a single randomized controlled trial or from a systematic review or meta-analysis of randomized controlled trials Evidence obtained from at least one well-designed controlled study without randomisation Evidence obtained from at least one other well designed quasi-experimental study Evidence obtained from well-designed nonexperimental descriptive studies, correlation studies and case studies Evidence obtained from expert committee reports or opinions and/or clinical experiences of respected authorities, or case reports

44 Surgery & Cancer Research

45 Changes to surgical training Changes due to reduced NHS funding Increased research red tape Reduced industry funding to surgery Reduced funding for clinical academic posts Challenges unique to surgical research

46 Multidisciplinary management of cancer patients Complex decision making Radiologist Pathologist Surgeon Oncologist Primary disease Is there a curative option (surgery)? Is patient fit for surgery? Is neo adjuvant treatment indicated? Post operation is adjuvant Rx indicated? What will predict response? Surgery Remove primary cancer (R0) Remove lymph nodes Minimise morbidity and mortality Restore anatomy Reconstruct

47 Surgical Research in Complex Decision Making Patient selection surgery neo/adjuvant treatment metastatic disease Biomarkers personalised / precision response to Rx Developing new technologies

48 Personalised Rx vs Intra-tumoural Heterogeneity

49 Technology: perception vs evidence

50 Living with Symptoms after Surgery Increasing group of survivors Patient-reported outcome measures Quality of life Function post-surgery

51 Surgical research in Cancer Prevention Understand basic science and biology Translational relevance Personalised / precision Population level Translational science Tissue banking Clinical trials Window trials Technical innovation

52 Population risk of cancer General population High Average Familial settings Sporadic Familial High penetrance Risk Environmental risk factors Diet & obesity Lifestyle Physical activity Smoking

53 Heritable Colorectal Cancer Risk Malcolm Dunlop, Edinburgh

54 Environment, energy imbalance & mutations in CRC obesity exercise diet Metabolism and energy signalling in cells energy imbalance within cells

55 Translational Research Opportunities

56 Dysregulated Wnt alters organoid budding phenotype in intestine wild-type Apc flox/flox small intestine

57 % budding Aspirin promotes budding phenotype in human FAP organoids control aspirin 29 d Percentage of budding organoids * normal colonic mucosa CTRL ASP CTRL ASP Normal mucosa Adenoma colonic adenoma *

58 Pretty good

59 Could do better

60 Future of cancer research and surgery Discovery Invention Innovation Cancer biology Genomics Risk stratification Routine data collection and integration NHS Technology

61 number cannot treat our way out of cancer Chris Wild, IARC PubMed Year cancer chemotherapy prevention chemoprevention

62 Why certain cancers increasing? prevalence in risk factors diet and lifestyle obesity fertility and age at first child screening/ incidental findings

63 If you could do one thing Reduce risk overall through behaviour change Detect cancer early with accurate diagnostic blood test Identify those at higher risk and prevent disease Intervention to prevent / decrease risk of disease Limit overtreatment of established cancer Routine NHS- integrated biobanking Biomarkers: normal pre-cursor lesion cancer recurrence

64 Aligning priorities Government Cancer Charities Public Healthcare professional

65 Scottish Cancer Foundation 1997 Facilitate research aimed at addressing the high incidence of cancer in Scotland, and the poor outcomes in patients who develop the disease Support collaborative cancer research Inform public on cancer prevention Provide advice to policy makers Promote cancer prevention

66 Scottish Cancer Prevention Network Move evidence on cancer risk reduction into everyday life, practice and policy Awareness about cancer prevention Advocacy for action on prevention Health inequalities in cancer prevention widening perspectives

67 Current architecture cancer research Spaces Methods/ technologies People

68 Aerial views.. Spaces Methods/ technologies People

69 Thank you IGMM

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominoperineal excision, of rectal cancer, 93 111 current controversies in, 106 109 extent of perineal dissection and removal of pelvic floor,

More information

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth

More information

National Breast Cancer Audit next steps. Martin Lee

National Breast Cancer Audit next steps. Martin Lee National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast

More information

Prophylactic Mastectomy State of the Art

Prophylactic Mastectomy State of the Art Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 6 th Brazilian Breast Cancer Conference Sao Paulo, Brazil 9 March 2012 Prophylactic Mastectomy State of the Art Monica Morrow

More information

!"#$ Oncology Outcomes Report

!#$ Oncology Outcomes Report !"#$ Oncology Outcomes Report The Cleveland Clinic Florida Cancer Institute is dedicated to the comprehensive care of patients with cancer. Oncologists collaborate with a variety of physicians across multiple

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 21 Annual Report Quality Study Adherence to Adjuvant Systemic Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center Grapevine

More information

ADJUVANT CHEMOTHERAPY...

ADJUVANT CHEMOTHERAPY... Colorectal Pathway Board: Non-Surgical Oncology Guidelines October 2015 Organization» Table of Contents ADJUVANT CHEMOTHERAPY... 2 DUKES C/ TNM STAGE 3... 2 DUKES B/ TNM STAGE 2... 3 LOCALLY ADVANCED

More information

Evolution of Breast Surgery

Evolution of Breast Surgery Evolution of Breast Surgery Natasha Rueth MD Surgical Oncologist Piper Breast Center and Alina Health Surgical Specialists Minneapolis, MN Definitions Radical Mastectomy: Removal of breast, chest muscles,

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 216 Annual Report Quality Study Adherence to Adjuvant System Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center Irving

More information

Farhat Din University of Edinburgh

Farhat Din University of Edinburgh Farhat Din University of Edinburgh number cannot treat our way out of cancer Chris Wild, IARC PubMed 180000 160000 140000 120000 100000 80000 60000 40000 20000 0 1800 1850 1900 1950 2000 2050 Year cancer

More information

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015 Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable

More information

Farhat Din University of Edinburgh

Farhat Din University of Edinburgh Farhat Din University of Edinburgh number cannot treat our way out of cancer Chris Wild, IARC PubMed 180000 160000 140000 120000 100000 80000 60000 40000 20000 0 1800 1850 1900 1950 2000 2050 Year cancer

More information

A superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.

A superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery. 1- A 63-year-old woman presents with a non-healing lesion on her right temple that has been present for over two years. On examination there is a 6 mm well defined lesion with central ulceration, telangiectasia

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 1 Annual Report Quality Study Adherence to Adjuvant Systemic Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center McKinney

More information

Breast Cancer MultiDisciplinary Approach

Breast Cancer MultiDisciplinary Approach Breast Cancer MultiDisciplinary Approach October 30, 2012 Kristi Dolcetti RN, CON, CBPNC-IC OTN Bookings Regional Cancer Care is booking indirect Patient visits for our Multidisciplinary Cancer Conferences

More information

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh What is Early rectal cancer? pt1t2n0m0 Predictors for LN involvement Size Depth Intramural

More information

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,

More information

Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options

Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate

More information

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?

More information

The Surgical Management of Colorectal Metastases

The Surgical Management of Colorectal Metastases 11th July 2017 Bowel Cancer UK The Surgical Management of Colorectal Metastases Ben Cresswell MD(Res) FRCS Consultant HPB Surgeon The Basingstoke Hepatobiliary Unit United Kingdom Surgical Management of

More information

Breast cancer: an update

Breast cancer: an update Breast cancer: an update Dr. Sanjeewa Seneviratne M.D, MRCS, Ph.D. Senior Lecturer and Honorary Consultant Surgeon Department of Surgery Faculty of Medicine, Colombo Plan The problem Screening & early

More information

Loco-Regional Management After Neoadjuvant Chemotherapy

Loco-Regional Management After Neoadjuvant Chemotherapy 1 Loco-Regional Management After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor of Surgery,

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.

More information

Radiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015

Radiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015 Radiation Treatment for Breast Cancer Melissa James Radiation Oncologist August 2015 OUTLINE External Beam Radiation treatment. (What is Radiation, doctor?) Role of radiation. (Why am I getting radiation,

More information

Radiotherapy Physics and Equipment

Radiotherapy Physics and Equipment Radiological Sciences Department Radiotherapy Physics and Equipment RAD 481 Lecture s Title: Introduction Dr. Mohammed EMAM Ph.D., Paris-Sud 11 University Vision :IMC aspires to be a leader in applied

More information

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment? Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen

More information

COLORECTAL CARCINOMA

COLORECTAL CARCINOMA QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF COLORECTAL CARCINOMA Ministry of Health Malaysia Malaysian Society of Colorectal Surgeons Malaysian Society of Gastroenterology & Hepatology Malaysian

More information

Shyam B. Paryani M.D., M.S., M.H.A & Nitesh N. Paryani, M.D. May 1 st, th Annual Cardiovascular & Medicine Symposium St. Augustine, Florida

Shyam B. Paryani M.D., M.S., M.H.A & Nitesh N. Paryani, M.D. May 1 st, th Annual Cardiovascular & Medicine Symposium St. Augustine, Florida Shyam B. Paryani M.D., M.S., M.H.A & Nitesh N. Paryani, M.D. May 1 st, 2015 16 th Annual Cardiovascular & Medicine Symposium St. Augustine, Florida Outline Terminology & Background A brief historical overview

More information

Neoadjuvant therapy a new pathway to registration?

Neoadjuvant therapy a new pathway to registration? Neoadjuvant therapy a new pathway to registration? Graham Ross, FFPM Clinical Science Leader Roche Products Ltd Welwyn Garden City, UK (full time employee) Themes Neoadjuvant therapy Pathological Complete

More information

Treatment strategy of metastatic rectal cancer

Treatment strategy of metastatic rectal cancer 35.Schweizerische Koloproktologie-Tagung Treatment strategy of metastatic rectal cancer Gilles Mentha University hospital of Geneva Bern, January 18th, 2014 Colorectal cancer is the third most frequent

More information

Breast Surgery: Yesterday, Today and Tomorrow

Breast Surgery: Yesterday, Today and Tomorrow Breast Surgery: Yesterday, Today and Tomorrow Baptist Hospital Gladys L. Giron, MD, FACS October 11,2014 Homestead Hospital Baptist Children s Hospital Doctors Hospital Baptist Cardiac & Vascular Institute

More information

Measure the Quality of Robot-Assisted Surgery

Measure the Quality of Robot-Assisted Surgery Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Colorectal cancer: diagnosis and management of colorectal cancer 1.1 Short title Colorectal cancer 2 The remit The Department

More information

Surgical treatment of BRCA mutated patients. Viviana Galimberti MD European Institute of Oncology Milan, Italy

Surgical treatment of BRCA mutated patients. Viviana Galimberti MD European Institute of Oncology Milan, Italy Surgical treatment of BRCA mutated patients Viviana Galimberti MD European Institute of Oncology Milan, Italy No pharmaceutical company funding was used I declare I have no conflicts of interest as regards

More information

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to: 1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications

More information

COLON AND RECTAL CANCER

COLON AND RECTAL CANCER COLON AND RECTAL CANCER Mark Sun, MD Clinical Associate Professor of Surgery University of Minnesota No disclosures Objectives 1) Understand the epidemiology, management, and prognosis of colon and rectal

More information

Treatment of Locally Advanced Rectal Cancer: Current Concepts

Treatment of Locally Advanced Rectal Cancer: Current Concepts Treatment of Locally Advanced Rectal Cancer: Current Concepts James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation

More information

Loco-Regional Management After Neoadjuvant Chemotherapy

Loco-Regional Management After Neoadjuvant Chemotherapy 1 Loco-Regional Management After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor of Surgery,

More information

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys? Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation Ronald J. Zagoria, M.D. UCSF Professor and Vice Chair Abdominal Imaging Section Chief Basics Where are your kidneys? What is ablation? Facts

More information

Colorectal Cancer Dashboard

Colorectal Cancer Dashboard Process Risk Assessment Presence or absence of cancer in first-degree blood relatives documented for patients with colorectal cancer Percent of patients with colorectal cancer for whom presence or absence

More information

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Advances in Breast Surgery Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Objectives Understand the surgical treatment of breast cancer Be able to determine when a lumpectomy

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. Annual Report Quality Study Improve process for breast biopsy patients to receive results of pathology reports Background A team from the Baylor Scott & White Medical Center

More information

RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY

RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY COLORECTAL CLINICAL SUBGROUP RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY Finalised by: Dr Simon Gollins Mr Andrew Renehan Dr Mark Saunders Mr Nigel Scott Dr Shabbir

More information

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Original Article Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Elmer E. van Eeghen 1, Frank den Boer 2, Sandra D. Bakker 1,

More information

Current innovations in colorectal surgery

Current innovations in colorectal surgery Current innovations in colorectal surgery KS Chapple Consultant Colorectal Surgeon Sheffield Teaching Hospitals NHS Trust Do we need more innovations? What innovations are there and are they worthwhile?

More information

It is a malignancy originating from breast tissue

It is a malignancy originating from breast tissue 59 Breast cancer 1 It is a malignancy originating from breast tissue including both early stages which are potentially curable, and metastatic breast cancer (MBC) which is usually incurable. Most breast

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, for early-stage triple-negative breast cancer, 740 742 in older early-stage breast cancer patients, 790 795 anti-her2-directed

More information

Jose Ramos. Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma

Jose Ramos. Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre Evolution of liver resection Better understanding

More information

RECENT ADVANCES IN PACREATIC NEOPLASMS. DrTK Marumo GIT/HPB Surgeon Charlotte Maxeke JohannesburgAcademic Hospital

RECENT ADVANCES IN PACREATIC NEOPLASMS. DrTK Marumo GIT/HPB Surgeon Charlotte Maxeke JohannesburgAcademic Hospital RECENT ADVANCES IN PACREATIC NEOPLASMS DrTK Marumo GIT/HPB Surgeon Charlotte Maxeke JohannesburgAcademic Hospital CONTENT: GENETICS EARLY DIAGNOSIS CHEMOTHERAPY NEOADJUVANT ADJUVANT PRIMARY PALLIATIVE

More information

Treatment of oligometastatic NSCLC

Treatment of oligometastatic NSCLC Treatment of oligometastatic NSCLC Jarosław Kużdżał Department of Thoracic Surgery Jagiellonian University Collegium Medicum, John Paul II Hospital, Cracow New idea? 14 NSCLC patients with solitary extrathoracic

More information

Mauricio Camus Appuhn Associate Professor Chief, Department of Surgical Oncology, Pontificia Universidad Católica de Chile

Mauricio Camus Appuhn Associate Professor Chief, Department of Surgical Oncology, Pontificia Universidad Católica de Chile May 18-20, 2017 18 a 20 de Maio / 2017 Castro's Park Hotel Surgery for metastatic breast cancer: the controversy of local surgery for metastatic breast cancer Cirurgia em câncer de mama metastático: a

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

COLON AND RECTAL CANCER

COLON AND RECTAL CANCER No disclosures COLON AND RECTAL CANCER Mark Sun, MD Clinical Assistant Professor of Surgery University of Minnesota Colon and Rectal Cancer Statistics Overall Incidence 2016 134,490 new cases 8.0% of all

More information

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B 04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture

More information

2018 National Academy of Medicine Annual Meeting

2018 National Academy of Medicine Annual Meeting 2018 National Academy of Medicine Annual Meeting October 15, 2018 Targeting Cancer with Precision Prevention Ernest Hawk, M.D., M.P.H. What is Precision Prevention? The concept of precision medicine prevention

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

Hepatobiliary and Pancreatic Malignancies

Hepatobiliary and Pancreatic Malignancies Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre

More information

Principles of Surgical Oncology ศาสตราจารย นายแพทย ธนพล ไหมแพง

Principles of Surgical Oncology ศาสตราจารย นายแพทย ธนพล ไหมแพง Principles of Surgical Oncology ศาสตราจารย นายแพทย ธนพล ไหมแพง Surgery is the oldest treatment for cancer and, until recently, was the only treatment that could cure patients with cancer. Ancient history

More information

Biomarkers to optimize treatment selection in colorectal cancer Edwin Pun HUI, MBChB, MD, FRCP (Lond & Edin)

Biomarkers to optimize treatment selection in colorectal cancer Edwin Pun HUI, MBChB, MD, FRCP (Lond & Edin) Recent advances in the management of CRC II 2017/12/17 (Sun.) 10:10-11:00 Biomarkers to optimize treatment selection in colorectal cancer Edwin Pun HUI, MBChB, MD, FRCP (Lond & Edin) Department of Clinical

More information

NCIN Conference Feedback 2015

NCIN Conference Feedback 2015 NCIN Conference Feedback 2015 Parallel Sessions Treatments (Black type is the topic; blue type are comments) The use of population and research data in the development of guidelines for cancer treatment

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated

More information

Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018

Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018 Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018 Summary: This document follows on from the findings of the CM-Path The

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction

Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction Version History Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction Version Summary of change Date Issued 2.0 Endorsed by the Governance Committee 20.02.08 2.1 Circulated

More information

Cancer Genetics Services in Scotland

Cancer Genetics Services in Scotland abcdefghijklm Cancer Genetics Services in Scotland Guidance to support the Implementation of Genetics Services for Breast, Ovarian and Colorectal Cancer Predisposition Scottish Cancer Group Cancer Genetics

More information

Audit Report. Colorectal Cancer Quality Performance Indicators. Patients diagnosed April 2014 March Published: July 2016

Audit Report. Colorectal Cancer Quality Performance Indicators. Patients diagnosed April 2014 March Published: July 2016 NORTH OF SCOTLAND PLANNING GROUP Colorectal Cancer Managed Clinical Network Audit Report Colorectal Cancer Quality Performance Indicators Patients diagnosed April 2014 March 2015 Published: July 2016 Mr

More information

CHAPTER 7 Concluding remarks and implications for further research

CHAPTER 7 Concluding remarks and implications for further research CONCLUDING REMARKS AND IMPLICATIONS FOR FURTHER RESEARCH CHAPTER 7 Concluding remarks and implications for further research 111 CHAPTER 7 Molecular staging of large sessile rectal tumors In this thesis,

More information

Audit Report. Breast Cancer Quality Performance Indicators. Patients diagnosed during Published: February 2018

Audit Report. Breast Cancer Quality Performance Indicators. Patients diagnosed during Published: February 2018 Breast Cancer Managed Clinical Network Audit Report Breast Cancer Quality Performance Indicators Patients diagnosed during 2016 Published: February 2018 Mr Douglas Brown NOSCAN Breast Cancer MCN Clinical

More information

Stage: The Language of Cancer

Stage: The Language of Cancer Stage: The Language of Cancer American Joint Committee on Cancer American College of Surgeons Chicago, IL Validating science. Improving patient care. No materials in this presentation may be repurposed

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective

More information

What is an Adequate Lumpectomy Margin in 2018?

What is an Adequate Lumpectomy Margin in 2018? What is an Adequate Lumpectomy Margin in 2018? Stuart J. Schnitt, M.D. Brigham and Women s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School Boston, MA None Disclosures Topics Current

More information

Adjuvant and neoadjuvant chemotherapy for rectal cancer: Expensive but little gain

Adjuvant and neoadjuvant chemotherapy for rectal cancer: Expensive but little gain Adjuvant and neoadjuvant chemotherapy for rectal cancer: Expensive but little gain Outline The problem Adjuvant therapy Neoadjuvant therapy Options Conclusion The problem 30 years ago: Local recurrence

More information

Gastric and Colon Cancer. Dr. Andres Wiernik 2017

Gastric and Colon Cancer. Dr. Andres Wiernik 2017 Gastric and Colon Cancer Dr. Andres Wiernik 2017 GASTRIC CANCER Gastric Cancer Classification Epidemiology General principles of Management 25% GE Junction Gastric Cancer 75% Gastric Cancer Epidemiology

More information

BOWEL CANCER. Causes of bowel cancer

BOWEL CANCER. Causes of bowel cancer A cancer is an abnormality in an organ that grows without control. The growth is often quite slow, but will continue unabated until it is detected. It can cause symptoms by its presence in the organ or

More information

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1 Caring for a Patient with Colorectal Cancer Tammy Triglianos RN, APRN-BC, AOCNP Nurse Practitioner, GI Oncology 10/15/2018 Objectives Describe common signs and symptoms of colorectal cancer Understand

More information

Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery

Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery Breast Cancer Res Treat (2016) 160:387 391 DOI 10.1007/s10549-016-4017-3 EDITORIAL Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery Monika Brzezinska 1 Linda J.

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

Ovarian Cancer Quality Performance Indicators

Ovarian Cancer Quality Performance Indicators Ovarian Cancer Quality Performance Indicators Patients diagnosed between October 2013 and September 2016 Publication date 20 February 2018 An Official Statistics publication for Scotland This is an Official

More information

Neoadjuvant Treatment of. of Radiotherapy

Neoadjuvant Treatment of. of Radiotherapy Neoadjuvant Treatment of Breast Cancer: Role of Radiotherapy Neoadjuvant Chemotherapy Many new questions for radiation oncology? lack of path stage to guide indications should treatment response affect

More information

HAVE YOU BEEN recently DIAGNOSED with stage II or stage III colon cancer?

HAVE YOU BEEN recently DIAGNOSED with stage II or stage III colon cancer? To learn more about the Oncotype DX Colon Cancer Test, please visit www. oncotypedx.com and talk to your health care team. For insurance, financial aid or other questions about the Oncotype DX test, please

More information

ESMO Breast Cancer Preceptorship Singapore November Special Issues in Treatment of Young Women with Breast Cancer

ESMO Breast Cancer Preceptorship Singapore November Special Issues in Treatment of Young Women with Breast Cancer ESMO Breast Cancer Preceptorship Singapore November 2017 Special Issues in Treatment of Young Women with Breast Cancer Prudence Francis MD Peter MacCallum Cancer Centre Melbourne, Australia Conflict of

More information

FAQ-Protocol 3. BRCA mutation carrier guidelines Frequently asked questions

FAQ-Protocol 3. BRCA mutation carrier guidelines Frequently asked questions ULast updated: 09/02/2015 Protocol 3 BRCA mutation carrier guidelines Frequently asked questions UQ: How accurate are the remaining lifetime and 5 year breast cancer risks in the table? These figures are

More information

Carcinoma del retto: Highlights

Carcinoma del retto: Highlights Carcinoma del retto: Highlights Stefano Cordio Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania Roma 17 Febbraio 2018 Disclosures Advisory Committee, research funding and speakers bureau

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal surgery prior as factor in laparoscopic colorectal surgery, 554 555 Abscess(es) CRC presenting as, 539 540 Adenocarcinoma of

More information

Breast Cancer Statistics

Breast Cancer Statistics 1 in 8 Breast Cancer Statistics Incidence Mortality Prevalence 2 Breast Cancer Incidence Breast Cancer Mortality Breast Cancer Prevalence ~$100,000 Female Breast Anatomy Breasts consist mainly of fatty

More information

Does Anesthesia influence Cancer recurrence? Dr Ian McConachie FRCA FRCPC London, ON, Canada

Does Anesthesia influence Cancer recurrence? Dr Ian McConachie FRCA FRCPC London, ON, Canada Does Anesthesia influence Cancer recurrence? Dr Ian McConachie FRCA FRCPC London, ON, Canada Why did my cancer come back? Inadequate resection Micro metastases Lymph spread Tumour biology Immune system

More information

Appendix 4 Urology Care Pathways

Appendix 4 Urology Care Pathways Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable

More information

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Goal of the study: 1.To assess whether patients at Truman

More information

Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer

Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer Reference: NHS England B14X08 Information Reader Box (IRB) to be inserted on inside front cover for documents of 6

More information

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA ESMO Cape Town 14 Feb 2018 Disclosures Advisory boards/lecturer/consultant-

More information

Updates on the Conflict of Postoperative Radiotherapy Impact on Survival of Young Women with Cancer Breast: A Retrospective Cohort Study

Updates on the Conflict of Postoperative Radiotherapy Impact on Survival of Young Women with Cancer Breast: A Retrospective Cohort Study International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(7): 14-18 I J M R

More information

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,

More information

Disclosures. Colorectal Cancer Update GAFP November Risk Assessment. Colon and Rectal Cancer The Challenge. Issues in Colon and Rectal Cancer

Disclosures. Colorectal Cancer Update GAFP November Risk Assessment. Colon and Rectal Cancer The Challenge. Issues in Colon and Rectal Cancer Disclosures Colorectal Cancer Update GAFP November 2006 Robert C. Hermann, MD Georgia Center for Oncology Research and Education Northwest Georgia Oncology Centers, PC WellStar Health System Marietta,

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 2016 Annual Report Identification of Disparity of Responsiveness Across Oncology Units at Baylor Scott & White Fort Worth Quality Study Improving Responsiveness of Staff for

More information

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania Aging Family history Early menarche Late menopause Nulliparity Estrogen / Progesterone use after menopause More than two alcoholic

More information

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology

More information

Role of MRI for Staging Rectal Cancer

Role of MRI for Staging Rectal Cancer Role of MRI for Staging Rectal Cancer High-resolution MRI has supplanted endoscopic ultrasound for staging rectal cancer. High-resolution MR images closely match histology and can show details such as

More information

Disclosures. Personalized Approaches to Gastrointestinal Cancers. Objectives. What is personalized cancer care. Go through some genomic studies

Disclosures. Personalized Approaches to Gastrointestinal Cancers. Objectives. What is personalized cancer care. Go through some genomic studies Personalized Approaches to Gastrointestinal Cancers Emily Groves, MD Colorectal Surgery Assistant Professor, Division of Surgical Oncology Disclosures None Objectives What is personalized medicine and

More information